What The Study Did:
In this randomized clinical trial, daily hydroxychloroquine didn’t prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early.
Authors:
Ravi K. Amaravadi, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https:/
/
media.
jamanetwork.
com/
(doi:10.1001/jamainternmed.2020.6319)
Editor’s Note:
The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Media advisory:
The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
https:/
/
jamanetwork.
com/
journals/
jamainternalmedicine/
fullarticle/
10.
1001/
jamainternmed.
2020.
6319?guestAccessKey=
053387bf-8cfb-4ea9-952c-1dd260fd4aed&utm_source=
For_The_Media&utm_medium=
referral&utm_campaign=
ftm_links&utm_content=
tfl&utm_term=
093020
This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-09/jn-eso092920.php